GLENMARK PHARMACEUTICALS Q2 FY25 Results

GLENMARK PHARMACEUTICALS has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 3,433.80 Cr
• Quarter-on-Quarter (QoQ) Change: 5.84% (Previous Quarter: Rs. 3,244.19 Cr )
• Year-on-Year (YoY) Change: 7.06% (Same Quarter Last Year: Rs. 3,207.38 Cr )

Profitability Metrics

• Net Profit: Rs. 354.49 Cr
• QoQ Profit Change: 4.19% (Previous Quarter: Rs. 340.24 Cr )
• YoY Profit Change: -657.77% (Same Quarter Last Year: Rs. -63.55 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. 12.55
• QoQ EPS Change: 4.06% (Previous Quarter: Rs. 12.06)
• YoY EPS Change: -532.76% (Same Quarter Last Year: Rs. -2.90)

Performance Summary

Mixed

GLENMARK PHARMACEUTICALS had a complex financial situation. Different parts of the business are performing differently, showing a changing market.

This analysis provides a snapshot of GLENMARK PHARMACEUTICALS's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.